Literature DB >> 2459094

In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.

S Yamamoto1, E Kuramoto, S Shimada, T Tokunaga.   

Abstract

A nucleic acid-rich fraction extracted and purified from BCG (MY-1) augmented natural killer (NK) cell activity of mouse spleen cells in vitro, and produced factor(s) which showed anti-viral activity and rendered normal macrophages cytotoxic towards tumor cells. These cellular responses were induced by the MY-1 digested preliminarily with RNase, but not by the MY-1 digested with DNase, indicating that DNA contained in MY-1 was essential for the responses. The function of the factor to activate macrophages was destroyed by treatment with a small amount of anti-interferon (IFN)-gamma antiserum or under acidic conditions (pH 2), but not by treatment with anti-IFN-alpha/beta antiserum, while the anti-viral activity was destroyed almost completely by treatment with anti-IFN-alpha/beta antiserum. It appears that DNA from BCG stimulated mouse spleen cells in vitro, resulting in augmentation of NK activity and production of IFN-alpha/beta and -gamma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459094      PMCID: PMC5917587          DOI: 10.1111/j.1349-7006.1988.tb00049.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  12 in total

1.  INTERFERON RESPONSES OF CHICK EMBRYO FIBROBLASTS TO NUCLEIC ACIDS AND RELATED COMPOUNDS.

Authors:  K E JENSEN; A L NEAL; R E OWENS; J WARREN
Journal:  Nature       Date:  1963-11-02       Impact factor: 49.962

2.  Inhibition of virus multiplication by foreign nucleic acid.

Authors:  Z ROTEM; R A COX; A ISAACS
Journal:  Nature       Date:  1963-02-09       Impact factor: 49.962

3.  Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid.

Authors:  J R Oehler; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

4.  In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.

Authors:  S Shimada; O Yano; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1986-08

5.  Induction of interferon synthesis by synthetic double-stranded polynucleotides.

Authors:  J Vilcek; M H Ng; A E Friedman-Kien; T Krawciw
Journal:  J Virol       Date:  1968-06       Impact factor: 5.103

6.  Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

7.  Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity.

Authors:  J R Oehler; L R Lindsay; M E Nunn; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

8.  Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.

Authors:  S Shimada; O Yano; H Inoue; E Kuramoto; T Fukuda; H Yamamoto; T Kataoka; T Tokunaga
Journal:  J Natl Cancer Inst       Date:  1985-03       Impact factor: 13.506

9.  The specificity of interferon induction in chick embryo cells by helical RNA.

Authors:  C Colby; M J Chamberlin
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

10.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

Authors:  T Tokunaga; H Yamamoto; S Shimada; H Abe; T Fukuda; Y Fujisawa; Y Furutani; O Yano; T Kataoka; T Sudo
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

View more
  35 in total

Review 1.  Modulation of asthmatic response by immunostimulatory DNA sequences.

Authors:  D Broide; J Y Cho; M Miller; J Nayar; G Stachnick; D Castaneda; M Roman; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  The response of human B lymphocytes to oligodeoxynucleotides.

Authors:  H Liang; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Introduction to immunostimulatory DNA sequences.

Authors:  J Van Uden; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 4.  Mechanisms of immune stimulation by bacterial DNA.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 5.  Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

Authors:  S Yamamoto; T Yamamoto; S Iho; T Tokunaga
Journal:  Springer Semin Immunopathol       Date:  2000

Review 6.  Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.

Authors:  H Kobayashi; A A Horner; E Martin-Orozco; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

7.  'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.

Authors:  Dong Yu; Ekambar R Kandimalla; Lakshmi Bhagat; Jin-Yan Tang; Yanping Cong; Jimmy Tang; Sudhir Agrawal
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

8.  Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Robert S Fujinami
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  Impact of site-specific nucleobase deletions on the arthritogenicity of DNA.

Authors:  Jan L Bjersing; Andrej Tarkowski; Ekambar R Kandimalla; Helen Karlsson; Sudhir Agrawal; L Vincent Collins
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

10.  Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.

Authors:  Ekambar R Kandimalla; Lakshmi Bhagat; Yukui Li; Dong Yu; Daqing Wang; Yan-Ping Cong; Sam S Song; Jimmy X Tang; Tim Sullivan; Sudhir Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.